EFFICACY OF BRAHMI VATI & ASWAGANDHARISTA IN MAJOR DEPRESSIVE DISORDER

Efficacy of Brahmi Vati & Aswagandharista in Major Depressive Disorder-Randomized Controlled Clinical Trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017227

Enrollment

Registered

2019-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F199- Other psychoactive substance use,unspecified

Interventions

Intervention1: Aswagandharista and brahmi vati: Group B- sample size 20- aswagandharistha 10 ml and bramhi vati 500 mg thrice in day after food for 60 days follow up 15th day 30 th day 45th day and 60

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 20 -60 years 2. Either sex 3.Subject fulfilling the diagnostic criteria of MDD(DSM 5)

Exclusion criteria

Exclusion criteria: 1.patient with axia II disorder like personality disorder 2.patient with axis Idisorders like schizophrenia, psychosis, anxiety diorders etc 3.avidence of active suicidal ideation 4.depression with psychotic symptoms 5.use of psychotropic therapy drugs within the past period of 4 weeks

Design outcomes

Primary

Measure	Time frame
Brahmi vati & Ashwagandharista is benefical in treating major depressive disorderTimepoint: 18 months	—

Secondary

Measure	Time frame
Brahmi vati & Ashwagandharista is not benefical in treating major depressive disorderTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Basavaraj R Tubaki

KAHER,shri BMK Ayurveda Mahavidhyalaya

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026